Alcon Other Operating Income or Expenses 2019-2025 | ALC
Alcon annual/quarterly other operating income or expenses history and growth rate from 2019 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Alcon other operating income or expenses for the quarter ending March 31, 2025 were $120M, a 1023.08% decline year-over-year.
- Alcon other operating income or expenses for the twelve months ending March 31, 2025 were $160M, a 219.4% decline year-over-year.
- Alcon annual other operating income or expenses for 2024 were $0.027B, a 115.79% decline from 2023.
- Alcon annual other operating income or expenses for 2023 were $-0.171B, a 44.12% decline from 2022.
- Alcon annual other operating income or expenses for 2022 were $-0.306B, a 98.7% increase from 2021.
| Alcon Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024 | $27 |
| 2023 | $-171 |
| 2022 | $-306 |
| 2021 | $-154 |
| 2020 | $-55 |
| 2019 | $-346 |
| 2018 | $-52 |
| Alcon Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $120 |
| 2024-12-31 | $44 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $1 |
| 2024-03-31 | $-13 |
| 2023-12-31 | $-80 |
| 2023-09-30 | $3 |
| 2023-06-30 | $-44 |
| 2023-03-31 | $-50 |
| 2022-12-31 | $-191 |
| 2022-09-30 | $-40 |
| 2022-06-30 | $-20 |
| 2022-03-31 | $-55 |
| 2021-12-31 | $-31 |
| 2021-09-30 | $-78 |
| 2021-06-30 | $-28 |
| 2021-03-31 | $-17 |
| 2020-12-31 | $158 |
| 2020-09-30 | $-76 |
| 2020-06-30 | $-53 |
| 2020-03-31 | $-84 |
| 2019-12-31 | $-103 |
| 2019-09-30 | $-72 |
| 2019-06-30 | $-73 |
| 2019-03-31 | $-98 |
| 2018-12-31 | |
| 2018-09-30 | $-28 |
| 2018-06-30 | $34 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.085B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.883B | 81.42 |
| Thermo Fisher Scientific (TMO) | United States | $156.566B | 18.94 |
| Edwards Lifesciences (EW) | United States | $44.869B | 29.42 |
| IDEXX Laboratories (IDXX) | United States | $41.386B | 47.56 |
| DexCom (DXCM) | United States | $32.894B | 50.84 |
| IQVIA Holdings (IQV) | United States | $27.789B | 15.56 |
| Mettler-Toledo (MTD) | United States | $24.832B | 29.53 |
| STERIS (STE) | Ireland | $22.191B | 24.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.420B | 0.00 |
| Waters (WAT) | United States | $17.111B | 24.14 |
| Hologic (HOLX) | United States | $14.260B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.443B | 29.62 |
| Penumbra (PEN) | United States | $8.922B | 70.02 |
| Masimo (MASI) | United States | $8.375B | 30.89 |
| Globus Medical (GMED) | United States | $7.627B | 18.17 |
| Glaukos (GKOS) | United States | $5.583B | 0.00 |
| Teleflex (TFX) | United States | $4.908B | 8.10 |
| Integer Holdings (ITGR) | United States | $3.925B | 20.57 |
| TransMedics (TMDX) | United States | $3.717B | 80.79 |
| PROCEPT BioRobotics (PRCT) | United States | $3.228B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.289B | 13.63 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Nihon Kohden (NHNKY) | Japan | $1.863B | 21.37 |
| Veracyte (VCYT) | United States | $1.841B | 25.83 |
| Alphatec Holdings (ATEC) | United States | $1.533B | 0.00 |
| Artivion (AORT) | United States | $1.302B | 121.96 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.984B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.865B | 4.60 |
| IRadimed (IRMD) | United States | $0.721B | 36.57 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.589B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.569B | 12.24 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 8.07 |
| AxoGen (AXGN) | United States | $0.514B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.416B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.385B | 8.96 |
| Treace Medical Concepts (TMCI) | United States | $0.355B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.221B | 13.41 |
| CVRx (CVRX) | United States | $0.209B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.110B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.40 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.17 |